[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367759-105":59,"doc-detail-367759-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","wisp1-drives-esophageal-squamous-cell-carcinoma-progression-via-modulation-of-cancer-associated-fibroblasts-and-immune-microenvironment-original-research","WISP1 Drives Esophageal Squamous Cell Carcinoma Progression via Modulation of Cancer-Associated Fibroblasts and Immune Microenvironment - Original Research","","WISP1/CCN4 shows abnormal expression in esophageal squamous cell carcinoma (ESCC), yet its functional significance remained unclear. This study integrates public WISP1 expression data, single-cell RNA sequencing, and clinical information with bioinformatics and experimental approaches to link WISP1 with prognosis, tumor microenvironment features, drug resistance, and immunotherapy response. Results show WISP1 upregulation in ESCC, associated immune suppression, and worse outcomes, with WISP1 enriched in cancer-associated fibroblasts driving ECM remodeling and reduced CAF and tumor cell migration/invasion.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/wisp1-drives-esophageal-squamous-cell-carcinoma-progression-via-modulation-of-cancer-associated-fibroblasts-and-immune-microenvironment-original-research/367759/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/wisp1-drives-esophageal-squamous-cell-carcinoma-progression-via-modulation-of-cancer-associated-fibroblasts-and-immune-microenvironment-original-research/367759.png","ImageObject",300,407,{"name":92,"@type":93},"Dipper","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main research question about WISP1 in ESCC?","Question",{"text":112,"@type":113},"The study aimed to clarify the specific role and importance of WISP1 (CCN4) in ESCC, including its links to clinical prognosis and the tumor microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study investigate WISP1’s relationship with ESCC progression?",{"text":117,"@type":113},"It combined bioinformatics analyses using public expression, scRNA-seq, and clinical data with experimental work, focusing on correlations with prognosis, tumor microenvironment, drug resistance, and immunotherapy response.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports a key role for WISP1 in cancer-associated fibroblasts?",{"text":121,"@type":113},"WISP1 was confirmed to be predominantly highly expressed in CAFs, and WISP1 knockdown in CAFs reduced proliferation, migration, invasion, and decreased ECM proteins such as COL1A1 and MMP14.",{"name":123,"@type":110,"acceptedAnswer":124},"What is the proposed clinical significance of WISP1 in ESCC?",{"text":125,"@type":113},"Higher WISP1 expression in ESCC patients was associated with poorer prognosis, and WISP1 is presented as a potential prognostic molecular marker and therapeutic target.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},367759,1790222651,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 23 July 2025  \nDOI 10.3389/fimmu.2025.1586790  \nOPEN ACCESS  \nEDITED BY  \nHan Moshage,  \nUniversity Medical Center Groningen, Netherlands  \nREVIEWED BY  \nXiaofeng Zhou,  \nJinan University, China Kirti Singh,  \nUniversity of California, San Francisco, United States  \n*CORRESPONDENCE  \nZhiqiang Zhang  \n [drzhiqiang@163.com](drzhiqiang@163.com)[ ](drzhiqiang@163.com)Xiujuan Li  \n [532508979@qq.com](532508979@qq.com)  \nRECEIVED 03 March 2025  \nACCEPTED 11 July 2025  \nPUBLISHED 23 July 2025  \nCITATION  \nYi Z, Zhang Q, Tao T, Liu X, Li H, Li X and Zhang Z (2025) WISP1 drives esophageal squamous cell carcinoma progression via modulation of cancer-associated ﬁbroblastsand immune microenvironment.  \nFront. Immunol. 16:1586790 .  \ndoi: 10.3389/fimmu.2025.1586790  \nCOPYRIGHT  \n© 2025 Yi, Zhang, Tao, Liu, Li, Li and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nWISP1 drives esophageal squamous cell carcinoma progression via modulation of cancer-associated ﬁbroblastsand immune microenvironment  \nZhiqiang Yi 1, Qiqi Zhang 1, Ting Tao 2, Xiaojia Liu 1, Hui Li 3, Xiujuan Li 4* and Zhiqiang Zhang 1*  \n1The Second Department of Gastroenterology, The First Afﬁliated Hospital of Xinjiang Medical University, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China, 2 Department of Burn and Plastic Surgery, Chongqing University Fuling Hospital, Chongqing, China, 3Central Laboratory of Xinjiang Medical University, Urumqi, China, 4 Department of Pathophysiology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China  \nBackground: Previous studies have reported abnormal expression of WNT1 inducible signaling pathway protein 1 (WISP1)/Cellular Communication Network Factor 4 (CCN4) in esophageal squamous cell carcinoma (ESCC) . However, its speciﬁc signiﬁcance remains unclear. To date, no in-depth research has been conducted to explore the role and importance of WISP1 in ESCC.  \nMethods: In this study, we downloaded the expression data of WISP1 (CCN4), Single-Cell RNA Sequencing (scRNA) data, and clinical information from public databases . A combination of bioinformatics analyses and experimental approaches was employed to comprehensively investigate the correlation between WISP1 expression and clinical prognosis, tumor microenvironment (TME), drug resistance, and response to immunotherapy. Additionally, the role of WISP1 in cancer-associated ﬁbroblasts (CAFs) and its underlying mechanisms were explored.  \nResults: Our ﬁndings revealed that WISP1 exhibited differential expression inmost analyzed cancers. In ESCC, WISP1 was upregulated and associated with TME characteristics, immune suppression, and drug resistance. Further analysis indicated that ESCC patients with higher WISP1 expression had relatively poorer prognoses. Moreover, it was conﬁrmed that WISP1 is predominantly highly expressed in CAFs. Knockdown of WISP1 in CAFs signiﬁcantly inhibited their proliferation, migration, and invasion capabilities, as well as markedly reduced the expression of extracellular matrix (ECM) proteins collagen type I alpha 1 chain (COL1A1) and matrix metallopeptidase 14 (MMP14) . Notably, co-culture experiments of CAFs with knocked-down WISP1 and ESCC cancer cells demonstrated that the migration and invasion abilities of ESCC cancer cells were also signiﬁcantly impaired.  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nConclusion: In summary, WISP1 is intricately involved in the pathogenesis of ESCC, exhibiting multifaceted role","cbCaipJOEC5aIxAK","https://ap.wps.com/l/cbCaipJOEC5aIxAK","pdf",19406613,"English","# Introduction\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What was the main research question about WISP1 in ESCC?\",\"answer\":\"The study aimed to clarify the specific role and importance of WISP1 (CCN4) in ESCC, including its links to clinical prognosis and the tumor microenvironment.\"},{\"question\":\"How did the study investigate WISP1’s relationship with ESCC progression?\",\"answer\":\"It combined bioinformatics analyses using public expression, scRNA-seq, and clinical data with experimental work, focusing on correlations with prognosis, tumor microenvironment, drug resistance, and immunotherapy response.\"},{\"question\":\"What evidence supports a key role for WISP1 in cancer-associated fibroblasts?\",\"answer\":\"WISP1 was confirmed to be predominantly highly expressed in CAFs, and WISP1 knockdown in CAFs reduced proliferation, migration, invasion, and decreased ECM proteins such as COL1A1 and MMP14.\"},{\"question\":\"What is the proposed clinical significance of WISP1 in ESCC?\",\"answer\":\"Higher WISP1 expression in ESCC patients was associated with poorer prognosis, and WISP1 is presented as a potential prognostic molecular marker and therapeutic target.\"}]","WISP1 Drives Esophageal Squamous Cell Carcinoma Progression via Modulation of Cancer-Associated Fibroblasts and Immune Microenvironment - Original Research | PDF",1790172450,48,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ecf08cd701b073f400fb5b1322e3c40.webp",983,1389,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f55a9c0753edf091c0120a3b9488cbc1.webp",982,1388,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da05094247181bb56a293c39b72fa218.webp",981,1387,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/18bfafb7eb39a7d3a7465302bda3147f.webp",980,1385]